SGMO Sangamo Therapeutics, Inc.
Biotechnology NasdaqCM
Trading Signals (SGMO)
Overall Signal
SELL
Strong sellish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $0.36
- Medium Support $0.42
- Weak Support $0.48
Resistance Levels
- Weak Resistance $0.6
- Medium Resistance $0.65
- Strong Resistance $0.71
Stop Loss Suggestions
- Conservative $0.58
- Moderate $0.62
- Aggressive $0.68
Analyst Ratings
Current Rating
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | NEUTRAL |
|
Short & Medium Term |
| Oscillators | BUY |
|
Short Term |
| Trend Indicators | BUY |
|
Medium Term |
| Volume Indicators | SELL |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities (SGMO)
Quarterly Outlook :
2026-04-03
Bullish Scenario
from current 55.86%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (13.19) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (40.32) is in bearish territory, indicating downward momentum. MACD line (-0.11) is above Signal line (-0.14) (bullish crossover), confirming upward momentum. Current Weekly ATR is 0.15, indicating the average weekly price range.
2026-04-03
Base Scenario
from current 6.98%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (13.19) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (40.32) is in bearish territory, indicating downward momentum. MACD line (-0.11) is above Signal line (-0.14) (bullish crossover), confirming upward momentum. Current Weekly ATR is 0.15, indicating the average weekly price range.
2026-04-03
Bearish Scenario
from current -55.86%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (13.19) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (40.32) is in bearish territory, indicating downward momentum. MACD line (-0.11) is above Signal line (-0.14) (bullish crossover), confirming upward momentum. Current Weekly ATR is 0.15, indicating the average weekly price range.
Annual Outlook
2026-04-03
Bullish Scenario
from current 111.71%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (13.19) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (40.32) is in bearish territory, indicating downward momentum. MACD line (-0.11) is above Signal line (-0.14) (bullish crossover), confirming upward momentum. Current Weekly ATR is 0.15, indicating the average weekly price range.
2026-04-03
Base Scenario
from current 13.96%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (13.19) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (40.32) is in bearish territory, indicating downward momentum. MACD line (-0.11) is above Signal line (-0.14) (bullish crossover), confirming upward momentum. Current Weekly ATR is 0.15, indicating the average weekly price range.
2026-04-03
Bearish Scenario
from current -111.71%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (13.19) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (40.32) is in bearish territory, indicating downward momentum. MACD line (-0.11) is above Signal line (-0.14) (bullish crossover), confirming upward momentum. Current Weekly ATR is 0.15, indicating the average weekly price range.
Technical Analysis (SGMO)
Trend Identification
EMA
Exponential Moving Average
Current price (0.54) is above both Short MA (0.52) and Long MA (0.52). This indicates strong bullish momentum. Short MA is crossing Long MA. This is a critical point signaling a potential trend change. Monitor closely. MAs (0.52, 0.52, 0.63) show mixed alignment, suggesting market indecision or range-bound activity.
MACD
Moving Average Convergence Divergence
MACD line is crossing the Signal line. This is a crucial point, signaling a potential trend change. Monitor closely. Both MACD and Signal lines are above the zero line, reinforcing bullish momentum (bullish territory).
ADX
Average Directional Index
ADX (21.89) indicates a developing or weakening trend. +DI (33.98) is above -DI (17.65), suggesting a bullish directional bias. Be cautious with current positions. Monitor for trend continuation or reversal signals.
Momentum Measurement
RSI (2026-04-03)
Relative Strength Index
RSI (50.93) is in the bullish territory, but not yet overbought. This indicates upward momentum. Monitor for continuation or signs of weakness.
OBV (2026-04-03)
On-Balance Volume
OBV (178702545.00) is falling, indicating selling pressure and distribution. Price is falling and OBV is falling. This is bearish confirmation, indicating selling pressure supports the price decrease. Consider holding short positions or initiating new ones. Volume is supporting the trend.
Stochastic (2026-04-03)
Stochastic Oscillator
Stochastics (%K: 17.15, %D: 34.57) are in the neutral zone (between 20 and 80). A bearish crossover (%K below %D) is observed. This indicates downward momentum. Be cautious if it's already in the oversold region.
CCI (2026-04-03)
Commodity Channel Index
CCI (19.65) is between 0 and +100. This indicates bullish momentum is present, but not yet extreme. A move above 0 from negative territory (bullish zero-line cross) can indicate a potential buy signal.
Volatility Measurement
ATR (2026-04-03)
Average True Range
Current ATR is 0.0500. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands (2026-04-03)
Volatility Bands
Current price (0.54) is within the Bollinger Bands (0.45 - 0.60). This suggests the price is trading within its typical volatility range. Price is above the Middle Band (0.52), indicating short-term bullish bias. Bollinger Bands are wide. This indicates high volatility. Prices tend to revert to the mean after extended periods of high volatility.
Risk Management & Potential Reversals (SGMO)
SAR (2026-04-03)
Parabolic Stop and Reverse
SAR points below price indicate bullish trend. Current SAR at 0.50 is 6.91% from price. Consider SAR as a potential stop-loss level to protect gains in an uptrend.
Stochastic (2026-04-03)
Oversold
Stochastic is in oversold territory (17.1). Monitor for potential bullish crossover or movement above 20, which could signal a reversal. Current crossover status: Bearish.
RSI (2026-04-03)
Reversal Perspective
Current RSI level is in neutral territory. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Bollinger Bands (2026-04-03)
Reversal Perspective
Bollinger Bands are widening, indicating high volatility and potential strong trend continuation.Price is in the upper half of the bands, suggesting a bullish bias.No indication of imminent volatility expansion or reversal.
Holder List Top 20 (SGMO)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| Vanguard Group Inc | INSTITUTIONAL | 9374728 | 4.17% | 2025-03-31 |
| Wasatch Advisors LP | INSTITUTIONAL | 6868766 | 3.06% | 2025-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | MUTUALFUND | 5985161 | 2.66% | 2025-03-31 |
| Blackrock Inc. | INSTITUTIONAL | 5445018 | 2.42% | 2025-03-31 |
| WASATCH FUNDS TRUST-Wasatch Ultra Growth Fund | MUTUALFUND | 4531718 | 2.02% | 2025-03-31 |
| Renaissance Technologies, LLC | INSTITUTIONAL | 3168107 | 1.41% | 2025-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | MUTUALFUND | 3073481 | 1.37% | 2025-03-31 |
| Geode Capital Management, LLC | INSTITUTIONAL | 2283450 | 1.02% | 2025-03-31 |
| Point72 Asset Management, L.P. | INSTITUTIONAL | 1998043 | 0.89% | 2025-03-31 |
| Ikarian Capital, LLC | INSTITUTIONAL | 1860179 | 0.83% | 2025-03-31 |
| Susquehanna International Group, LLP | INSTITUTIONAL | 1809550 | 0.81% | 2025-03-31 |
| Jacobs Levy Equity Management, Inc. | INSTITUTIONAL | 1297785 | 0.58% | 2025-03-31 |
| Millennium Management Llc | INSTITUTIONAL | 1172092 | 0.52% | 2025-03-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | MUTUALFUND | 1054402 | 0.47% | 2025-04-30 |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | MUTUALFUND | 917417 | 0.41% | 2025-02-28 |
| BlackRock Funds-BlackRock Advantage Small Cap Core Fund | MUTUALFUND | 627426 | 0.28% | 2025-02-28 |
| Invesco Exchange-Traded Fund Trust-Invesco RAFI US 1500 Small-Mid ETF | MUTUALFUND | 419976 | 0.19% | 2025-04-30 |
| Invesco Exch-Trd Fd. TRT-Invesco FTSE RAFI US 1500 Small-Mid ETF | MUTUALFUND | 419976 | 0.19% | 2025-04-30 |
| Delaware Group Equity Funds IV-Macquarie Healthcare Fund | MUTUALFUND | 400000 | 0.18% | 2025-03-31 |
| iShares Trust-iShares Genomics Immunology and Healthcare ETF | MUTUALFUND | 351159 | 0.16% | 2025-04-30 |